Treatment IND protocol announced for Pneumocystis carinii pneumonia.
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications; D000935:Antifungal Agents / Q000009:adverse effects / Q000627:therapeutic use*; D053626:Atovaquone; D002985:Clinical Protocols; D015507:Drugs, Investigational / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D009285:Naphthoquinones / Q000009:adverse effects / Q000627:therapeutic use*; D011020:Pneumonia, Pneumocystis / Q000188:drug therapy*
D000935:Antifungal Agents; D015507:Drugs, Investigational; D009285:Naphthoquinones; D053626:Atovaquone